respiratory

News

Respiri brings wheezo device and app to US market

Australian digital health company Respiri has rolled out its wheezo device, app and healthcare monitoring portal at Michigan Children's Hospital, the first US customer for the technology.

Events

Partner Content

2nd ARDS Drug Development Summit

Only Industry-Specific Event for ARDS Drug Developers

News

Pfizer makes bid for ResApp and its respiratory diagnosis ap...

Pfizer's Australian unit has tabled an offer to buy ResApp Health and its smartphone apps for the management and diagnosis of respiratory diseases in a deal that values the digital health c

News

Overuse of asthma inhalers linked to severe attacks; study

Data from a massive real-world study of asthma patients has suggested that overuse of inhalers is widespread and leading to an elevated risk of severe exacerbations.

News

Sandoz bulks up ahead of possible sale with Coalesce buy

Novartis may be planning to sell off its generics business Sandoz, but that hasn't stopped it investing in the unit ahead of a decision on its future later this year.

News

Synairgen slumps as inhaled COVID drug fails pivotal test

UK biotech Synairgen saw the value of its shares crater after its inhaled interferon beta therapy SNG001 was found to provide no benefit to people hospitalised with COVID-19.

Respiri brings wheezo device and app to US market

2nd ARDS Drug Development Summit

Pfizer makes bid for ResApp and its respiratory diagnosis ap...

Overuse of asthma inhalers linked to severe attacks; study

Sandoz bulks up ahead of possible sale with Coalesce buy

Synairgen slumps as inhaled COVID drug fails pivotal test

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

respiratory

Editor's Picks